v3.26.1
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Cash flows from operating activities:    
Net loss $ (3,556,415) $ (1,945,573)
Adjustments to reconcile net loss to net cash used in operating activities:    
Accrued interest 3,089 2,947
Change in fair value of liability classified warrants (9,916)
Consultant compensation 46,093
Stock-based compensation 8,743 16,251
Depreciation expense 6,533
Changes in operating assets and liabilities:    
Unbilled receivable 420,345 102,113
Prepaid expenses and other assets 1,292,926 433,659
Accounts payable (1,663,513) (741,784)
Accrued expenses and other liabilities (12,633) 388,798
Net cash used in operating activities (3,500,925) (1,707,412)
Cash flows from financing activities:    
Proceeds from public offerings 1,100,006
Proceeds from warrant exercises 347,995
Transaction costs from public offerings (142,950)
Repayment of financed insurance premiums (63,947) (47,225)
Net cash (used in) provided by financing activities (63,947) 1,257,826
Decrease in cash and cash equivalents (3,564,872) (449,586)
Cash and cash equivalents beginning of period 4,310,354 3,502,077
Cash and cash equivalents end of period 745,482 3,052,491
Supplemental disclosure of non-cash financing activities:    
Transaction costs included in accounts payable $ 6,090 $ 61,243

Source

PDF HTML
ZIP XBRL